A placebo-controlled add-on trial of the Ampakine, CX516, for cognitive deficits in schizophrenia
- Donald C. Goff
- , J. Steven Lamberti
- , Andrew C. Leon
- , Michael F. Green
- , Alexander L. Miller
- , Jayendra Patel
- , Theo Manschreck
- , Oliver Freudenreich
- , Steven A. Johnson
Research output: Contribution to journal › Article › peer-review
176
Link opens in a new tab
Scopus
citations